Daundong, Perlyn .
HRN: 26-05-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/17/2024
10/24/2024
PO
500mg
Q8
Hepatic Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes